title: Current endovascular treatment options of dural venous sinus thrombosis: a review of the literature.
abstract: Dural venous sinus thrombosis, although relatively rare, has the propensity to cause potentially fatal conditions, such as stroke. This review presents the current endovascular treatment and management options for dural venous sinus thrombosis and provides current recommendations. Select databases were utilized for an exhaustive literature search with key search terms in efforts to obtain all relevant cases to endovascular treatment of dural venous sinus thrombosis. Recommendations for management options include initially the use of anticoagulation. For patients with a poor prognosis, local thrombolysis with urokinase or recombinant tissue plasminogen activator should be initiated. Ultimately, if the patient is not a good candidate for local or systemic thrombolysis, treatment via rheolytic thrombectomy should be employed.
authors: Department of Neurological Surgery, University of Medicine and Dentistry of New Jersey, Newark, New Jersey USA.
authors: Nihar B
authors: NB
authors: Gala
authors: Nitin
authors: N
authors: Agarwal
authors: James
authors: J
authors: Barrese
authors: Chirag D
authors: CD
authors: Gandhi
authors: Charles Joseph
authors: CJ
authors: Prestigiacomo
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage; D057510:Endovascular Procedures / Q000379:methods*; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D012851:Sinus Thrombosis, Intracranial / Q000175:diagnosis* / Q000628:therapy*; D015912:Thrombolytic Therapy / Q000379:methods; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator